Literature DB >> 25527522

Cardiovascular disease predicts diabetic peripheral polyneuropathy in subjects with type 2 diabetes: A 10-year prospective study.

Juan Ybarra-Muñoz1, Jeronimo Jurado-Campos2, Maria Garcia-Gil3, Edurne Zabaleta-Del-Olmo4, Teresa Mir-Coll5, Adelaida Zabalegui6, Josep Vidal7, June H Romeo8.   

Abstract

BACKGROUND: The relationship between cardiovascular disease and diabetic peripheral neuropathy is mainly sustained by data retrieved from cross-sectional studies focused on cardiovascular risk factors. We aimed to assess the presence of cardiovascular disease as a risk factor for developing diabetic peripheral neuropathy in a type 2 diabetes mellitus population.
METHOD: A 10-year prospective, primary care, multicentre study in a randomly selected cohort. Cardiovascular disease presence included stroke, coronary artery disease and/or peripheral ischaemia. Diabetic peripheral neuropathy diagnosis was based on clinical neurological examination as well as the neuropathy symptoms score and nerve conduction studies.
RESULTS: Three hundred and ten (N=310) patients were initially recruited. Two-hundred and sixty seven (N=267) patients were included in the study. Diabetic peripheral neuropathy cumulative incidence was 18.3% (95% confidence intervals 14.1-23.4; N=49). Diabetic peripheral neuropathy development was significantly more frequent in participants presenting with cardiovascular disease at baseline (P=0.01). In the final logistic regression analysis, the presence of cardiovascular disease remained associated with an increased risk for diabetic peripheral neuropathy (odds ratio 2.32, 95% confidence intervals 1.03-5.22) in addition to diabetes duration and low density lipoprotein-cholesterol levels.
CONCLUSIONS: In our series, type 2 diabetes mellitus patients with cardiovascular disease at baseline present with an increased risk of developing diabetic peripheral neuropathy at 10 years of follow-up. Our results suggest that measures aimed at the prevention, control and treatment of cardiovascular disease can also help prevent diabetic peripheral neuropathy development. © The European Society of Cardiology 2014.

Entities:  

Keywords:  Cardiac autonomic neuropathy; cardiovascular disease; diabetic peripheral neuropathy; low density lipoprotein-cholesterol; prospective studies; type 2 diabetes mellitus

Mesh:

Year:  2014        PMID: 25527522     DOI: 10.1177/1474515114565215

Source DB:  PubMed          Journal:  Eur J Cardiovasc Nurs        ISSN: 1474-5151            Impact factor:   3.908


  5 in total

1.  Factors associated with peripheral neuropathy in type 2 diabetes: Subclinical versus confirmed neuropathy.

Authors:  Yogendranathsing Unmar; Mohammad Ishraq Zafar; Feng Gao
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2017-06-06

Review 2.  Risk Factors and Comorbidities in Diabetic Neuropathy: An Update 2015.

Authors:  Nikolaos Papanas; Dan Ziegler
Journal:  Rev Diabet Stud       Date:  2015-08-10

Review 3.  Diabetic Polyneuropathy in Type 2 Diabetes Mellitus: Inflammation, Oxidative Stress, and Mitochondrial Function.

Authors:  Luis Miguel Román-Pintos; Geannyne Villegas-Rivera; Adolfo Daniel Rodríguez-Carrizalez; Alejandra Guillermina Miranda-Díaz; Ernesto Germán Cardona-Muñoz
Journal:  J Diabetes Res       Date:  2016-12-12       Impact factor: 4.011

4.  The risk factors for diabetic peripheral neuropathy: A meta-analysis.

Authors:  Xiuxiu Liu; Yuyan Xu; Miaomiao An; Qibing Zeng
Journal:  PLoS One       Date:  2019-02-20       Impact factor: 3.240

5.  Peripheral Neuropathy as a Risk Factor for Developing Cardiovascular Disease in Diabetic Patients.

Authors:  Ghassan AlGhamdi; Hisham Saati; Enad Almotairi; Basil S Alsofiani; Abdulhalim J Kinsara
Journal:  Cureus       Date:  2020-12-05
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.